Cannabis Bioscience International Holdings (CBIH) EBT Margin (2022 - 2026)
Cannabis Bioscience International Holdings' (CBIH) quarterly EBT Margin came in at 928.47% in Q1 2026, up 8758.0% year-on-year from 10.48% in Q1 2025, and down 399.01% quarter-over-quarter from 186.06% in Q4 2025.
Cannabis Bioscience International Holdings (CBIH) EBT Margin (2022 - 2026) Analysis & Trends
Cannabis Bioscience International Holdings has disclosed EBT Margin across 5 years of filings, most recently posting 928.47% for Q1 2026.
- EBT Margin for Q1 2026 came in at 928.47%, up 8758.0% year-over-year; the trailing twelve-month figure through Feb 2026 was 431.09% (down 34337.0% YoY), and the FY2025 annual result was 184.02%, up 1576.0% from the prior year.
- EBT Margin came in at 928.47% for Q1 2026 at Cannabis Bioscience International Holdings, down from 186.06% in the prior quarter.
- In the past five years, EBT Margin ranged from a high of 24.08% in Q2 2024 to a low of 1016.05% in Q1 2025.
- The 5-year median for EBT Margin is 323.53% (2025), against an average of 413.01%.
- Across the five-year window, EBT Margin soared 61898 bps in 2024 and tumbled 70394 bps in 2025, its largest moves.
- Cannabis Bioscience International Holdings' EBT Margin stood at 266.27% in 2022, then soared by 44 bps to 148.26% in 2023, then surged by 38 bps to 92.03% in 2024, then slumped by 102 bps to 186.06% in 2025, then slumped by 399 bps to 928.47% in 2026.
- The last three EBT Margin figures came in at 928.47% (Q1 2026), 186.06% (Q4 2025), and 380.79% (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 10.97% |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 33.51% |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 40.73% |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 25.87% |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 30.30% |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.35% |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -156.77% |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -16.70% |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 41.45% |
| 10 | Cannabis Bioscience International Holdings | - | - | 8,160.00 | -928.47% |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | -928.47% |
| Nov 30, 2025 | -186.06% |
| Aug 31, 2025 | -380.79% |
| May 31, 2025 | -679.85% |
| Feb 28, 2025 | -1,016.05% |
| Nov 30, 2024 | -92.03% |
| Aug 31, 2024 | -55.87% |
| May 31, 2024 | 24.08% |
| Feb 29, 2024 | -574.53% |
| Nov 30, 2023 | -148.26% |
| Aug 31, 2023 | -249.64% |
| May 31, 2023 | -594.90% |
| Feb 28, 2023 | -633.45% |
| Nov 30, 2022 | -266.27% |